ArticleJournal of clinical practice and research2026
Second Screening for Celiac Disease in First-Degree Relatives of Pediatric Index Cases: A Single-Center Observational Study.
Article in Journal of clinical practice and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study investigated new seropositivity detected during repeat screening among first-degree relatives of pediatric index cases with celiac disease (CD) who were seronegative at initial screening. Materials and Methods: This single-center, observational, family-based screening study was conducted at a tertiary pediatric gastroenterology center. First-degree relatives of 117 pediatric index cases with biopsy-confirmed CD were invited for screening. CD screening was performed using tissue transglutaminase immunoglobulin A, with tissue transglutaminase immunoglobulin G used in cases of low total immunoglobulin A. Individuals with seropositivity underwent upper gastrointestinal endoscopy with duodenal biopsy. Histopathologic findings were evaluated according to the Marsh classification. Among participants with negative initial serology, those whose first screening had been performed at least 1 year earlier underwent repeat serologic screening. Results: Of the 462 invited first-degree relatives, 376 participated in the initial screening. Seropositivity was detected in 5.6% of participants, and biopsy-confirmed CD was established in 5.0%. Among the 355 individuals with negative initial serology, 101 underwent repeat screening after a median interval of 3.0 years. New seropositivity was detected in 4 of these 101 individuals [3.9%; exact binomial 95% CI: 1.1-9.8], and all had biopsy-confirmed CD. Three of the newly identified cases were siblings who had been screened in early childhood. No significant association was found between the presence of symptoms and serologic positivity at either screening. Conclusion: First-degree relatives of pediatric patients with CD represent a high-risk group in whom new seropositivity may emerge over time. Repeat screening, particularly in relatives first screened during early childhood, may improve case detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.